"The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions"
We are: Licensed by the New Jersey Dept
Overall, current epidemiologic evidence shows that GLP-1RAs consistently induce fat loss accompanied by proportional lean tissue reduction (Table 1)
Weight loss drugs may be an option for you if you have obesity, which is defined as a body mass index (BMI) of 30 or higher
(Refer to Table 1 for details of clinical trials evaluating GLP-1 and insulin)
If you experience severe, persistent abdominal pain while taking GLP-1 medications, stop taking the medication and seek urgent medical attention, as this could indicate pancreatitis or gallbladder disease